X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Dr. Reddys - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs DR. REDDYS LAB - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD DR. REDDYS LAB ALEMBIC LTD/
DR. REDDYS LAB
 
P/E (TTM) x 74.6 26.9 277.2% View Chart
P/BV x 2.8 2.8 99.9% View Chart
Dividend Yield % 0.4 1.0 39.6%  

Financials

 ALEMBIC LTD   DR. REDDYS LAB
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-16
DR. REDDYS LAB
Mar-16
ALEMBIC LTD/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs534,383 1.2%   
Low Rs292,750 1.1%   
Sales per share (Unadj.) Rs4.7920.1 0.5%  
Earnings per share (Unadj.) Rs8.8126.1 7.0%  
Cash flow per share (Unadj.) Rs9.0183.0 4.9%  
Dividends per share (Unadj.) Rs0.1520.00 0.8%  
Dividend yield (eoy) %0.40.6 65.2%  
Book value per share (Unadj.) Rs27.7685.8 4.0%  
Shares outstanding (eoy) m267.03170.61 156.5%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x8.73.9 224.4%   
Avg P/E ratio x4.728.3 16.5%  
P/CF ratio (eoy) x4.619.5 23.4%  
Price / Book Value ratio x1.55.2 28.5%  
Dividend payout %1.715.9 10.8%   
Avg Mkt Cap Rs m10,962608,481 1.8%   
No. of employees `000NA21.7 0.0%   
Total wages/salary Rs m23831,874 0.7%   
Avg. sales/employee Rs ThNM7,244.4-  
Avg. wages/employee Rs ThNM1,470.9-  
Avg. net profit/employee Rs ThNM992.8-  
INCOME DATA
Net Sales Rs m1,260156,978 0.8%  
Other income Rs m2642,693 9.8%   
Total revenues Rs m1,524159,671 1.0%   
Gross profit Rs m8334,587 0.2%  
Depreciation Rs m619,705 0.6%   
Interest Rs m0824 0.0%   
Profit before tax Rs m28526,751 1.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m2,0960-   
Extraordinary Inc (Exp) Rs m-320-   
Tax Rs m65,237 0.1%   
Profit after tax Rs m2,34321,514 10.9%  
Gross profit margin %6.622.0 29.8%  
Effective tax rate %2.119.6 10.9%   
Net profit margin %185.913.7 1,356.4%  
BALANCE SHEET DATA
Current assets Rs m1,689118,201 1.4%   
Current liabilities Rs m48668,368 0.7%   
Net working cap to sales %95.431.7 300.6%  
Current ratio x3.51.7 200.9%  
Inventory Days Days21760 361.6%  
Debtors Days Days8197 83.6%  
Net fixed assets Rs m1,62472,265 2.2%   
Share capital Rs m534853 62.6%   
"Free" reserves Rs m5,960111,548 5.3%   
Net worth Rs m7,404117,009 6.3%   
Long term debt Rs m10410,690 1.0%   
Total assets Rs m8,010200,104 4.0%  
Interest coverage x950.733.5 2,840.8%   
Debt to equity ratio x00.1 15.4%  
Sales to assets ratio x0.20.8 20.1%   
Return on assets %29.311.2 262.0%  
Return on equity %31.618.4 172.1%  
Return on capital %31.321.6 144.9%  
Exports to sales %2.946.3 6.4%   
Imports to sales %28.99.0 322.4%   
Exports (fob) Rs m3772,618 0.1%   
Imports (cif) Rs m36414,050 2.6%   
Fx inflow Rs m3775,405 0.0%   
Fx outflow Rs m36527,115 1.3%   
Net fx Rs m-32848,290 -0.7%   
CASH FLOW
From Operations Rs m34640,476 0.9%  
From Investments Rs m-48-19,421 0.2%  
From Financial Activity Rs m-301-17,009 1.8%  
Net Cashflow Rs m-34,046 -0.1%  

Share Holding

Indian Promoters % 64.0 25.5 251.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 5.4 3.7%  
FIIs % 9.7 35.3 27.5%  
ADR/GDR % 0.0 18.5 -  
Free float % 26.1 15.3 170.6%  
Shareholders   54,701 75,885 72.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   VENUS REMEDIES  ORCHID PHARMA LTD  NOVARTIS  TTK HEALTHCARE  SHASUN PHARMA  

Compare ALEMBIC LTD With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens 200 Points Higher; Lupin & Axis Bank Top Gainers(09:30 am)

Majority of Asian stock indices are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.07%, while the Hang Seng is up 1.06%.

Related Views on News

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Dr Reddy's: Major Business Segments Come Under Pressure (Quarterly Results Update - Detailed)

Sep 12, 2016

Dr Reddy's has announced the results for first quarter of FY17 (1QFY17). The company has reported decline in the sales by 13.9% YoY while net profits declined by 79.8 % YoY.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Aug 22, 2017 11:14 AM

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 8-QTR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS